Sujal Patel-led Nautilus Biotechnology goes public as it tackles ambitious plan to analyze proteins

Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. (Nautilus Photo)Nautilus Biotechnology is emerging as Seattle’s newest publicly traded company this week, taking advantage of the mania over SPACs to raise $345 million to fuel a new approach that could accelerate biomedical research and transform drug development. The Seattle company, which will trade on Nasdaq under the ticker NAUT starting…
« Previous post: | Next post: »